Cetera Trust Company N.A Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Cetera Trust Company N.A boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,055 shares of the company’s stock after acquiring an additional 85 shares during the period. HCA Healthcare accounts for 1.6% of Cetera Trust Company N.A’s portfolio, making the stock its 15th largest holding. Cetera Trust Company N.A’s holdings in HCA Healthcare were worth $2,418,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Terra Nova Asset Management LLC lifted its holdings in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares during the period. Massmutual Trust Co. FSB ADV raised its stake in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC boosted its stake in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management grew its holdings in HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. lifted its position in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $314.34 on Wednesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The business has a 50-day moving average of $315.10 and a 200-day moving average of $353.07. HCA Healthcare, Inc. has a 1 year low of $278.68 and a 1 year high of $417.14. The firm has a market capitalization of $79.62 billion, a P/E ratio of 14.19, a PEG ratio of 1.06 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.84%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Truist Financial lowered their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $385.27.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.